# digital pathology (audio feeds) — RSS Amplifier Recent posts from the 2 feeds in the RSS Amplifier directory that cover digital pathology. Page: Feed: --- ## 242: Are Foundation Models Really Better for Digital Pathology? Podcast with Panu Kauppila _2026-08-20 · Digital Pathology Podcast_ Send us Fan Mail What good is a powerful foundation model if it slows the pathologist down, can’t explain its result, or doesn’t fit the clinical workflow? Foundation models are gaining attention across digital pathology. But they’re not finished clinical tools by themselves. In this episode of the Digital Pathology Podcast, I speak with Panu Kauppila, Chief Product Officer at Aiforia , about what… [Listen](https://www.buzzsprout.com/410071/episodes/19675792-242-are-foundation-models-really-better-for-digital-pathology-podcast-with-panu-kauppila.mp3) ## 241: Screening Efficiency Over Experience: Rethinking Cytology Expertise _2026-08-17 · Digital Pathology Podcast_ Send us Fan Mail Does more experience automatically make a cytotechnologist more accurate—or does where they look first matter more? In DigiPath Digest #50, I review a digital cytology eye-tracking study that challenges the assumption that diagnostic accuracy improves steadily with years of practice. The researchers tracked the visual behavior of 100 board-certified cytotechnologists with 1 to 40… [Listen](https://www.buzzsprout.com/410071/episodes/19650385-241-screening-efficiency-over-experience-rethinking-cytology-expertise.mp3) ## [An Autopsy of Four Drugs: The Cause of Death for Four AstraZeneca and Novartis Oncology Programs](https://beyondtheslide.substack.com/p/an-autopsy-of-four-drugs-the-cause) _2026-08-14 · Dr. Luis Cano · Beyond the Slide_ Four Cases, One Broken Chain ## 240: Computational Pathology Is Changing Companion Diagnostics _2026-08-13 · Digital Pathology Podcast_ Send us Fan Mail Can a treatment decision depend on whether one pathologist sees 45% biomarker positivity and another sees 55%? Visual immunohistochemistry scoring helped establish precision oncology. But as targeted therapies become more sensitive to subtle biological differences, categorical scores such as 0, 1+, 2+, and 3+ may no longer capture the information needed to identify the right… [Listen](https://www.buzzsprout.com/410071/episodes/19641575-240-computational-pathology-is-changing-companion-diagnostics.mp3) ## [When Target Expression Isn't Enough](https://beyondtheslide.substack.com/p/tumor-microenvironment-adc-blind-spot) _2026-08-07 · Dr. Luis Cano · Beyond the Slide_ The blind spot antibody-drug conjugates share with pathology AI ## [We Didn't Get Foundation Models Wrong. We Got the Question Wrong.](https://beyondtheslide.substack.com/p/we-didnt-get-foundation-models-wrong) _2026-07-31 · Dr. Luis Cano · Beyond the Slide_ Better perception alone won’t solve digital pathology’s standardization problem ## 245: Why Going Slow Is Killing Digital Pathology Adoption | Syed T. Hoda, M.D. _2026-07-29 · Digital Pathology Podcast_ Send us Fan Mail Is your digital pathology rollout moving so slowly that it’s creating a fragmented workflow instead of transforming the department? In this episode of the Digital Pathology Podcast, I speak with Dr. Syed Hoda, Director of Digital Pathology at NYU, about why gradual implementation may no longer be the best approach to digital pathology adoption. Dr. Hoda explains how NYU used an… [Listen](https://www.buzzsprout.com/410071/episodes/19568259-245-why-going-slow-is-killing-digital-pathology-adoption-syed-t-hoda-m-d.mp3) ## [The Relocation of Fragility : Innovation doesn't eliminate fragility. It redistributes it.](https://beyondtheslide.substack.com/p/the-relocation-of-fragility-innovation) _2026-07-24 · Dr. Luis Cano · Beyond the Slide_ THE MONTHLY REVIEW ## 244: Why AI Still Hasn't Revolutionized Drug Discovery (Yet) | Thibault Geoui, PhD _2026-07-22 · Digital Pathology Podcast_ Send us Fan Mail If AI is already being used across the drug development pipeline, why hasn’t its impact matched the investment? AI can help researchers review scientific literature, predict protein structures, prioritize molecules, assess toxicity, support clinical trials, and monitor adverse events. But access to better tools doesn’t automatically create better drugs. In this episode, I speak… [Listen](https://www.buzzsprout.com/410071/episodes/19531860-244-why-ai-still-hasn-t-revolutionized-drug-discovery-yet-thibault-geoui-phd.mp3) ## [THE COLD WAR OF DRUG DEVELOPMENT](https://beyondtheslide.substack.com/p/the-cold-war-of-drug-development) _2026-07-17 · Dr. Luis Cano · Beyond the Slide_ This isn't a war to be won. It's a race to not be the one left behind. ## [Never miss a game (Sponsored)](https://crawlproof.com/a/m97Z8HzmPzRE) _2026-07-17 · **Sponsored**_ Follow any team; get an hour and one-minute web and email reminders. ## [Healthcare Didn't Adapt to AI. AI Adapted to Healthcare.](https://beyondtheslide.substack.com/p/healthcare-didnt-adapt-to-ai-ai-adapted) _2026-07-10 · Dr. Luis Cano · Beyond the Slide_ Why disruptive technologies lose their transformative power when organizations force them into legacy frameworks. ## [The Sophistication Trap : Why More Technology Doesn’t Necessarily Create More Value](https://beyondtheslide.substack.com/p/the-sophistication-trap-why-more) _2026-07-03 · Dr. Luis Cano · Beyond the Slide_ The hospital had done the transition right. ## 243: How to Teach AI to Healthcare Professionals | Podcast with Candice Chu _2026-07-02 · Digital Pathology Podcast_ Send us Fan Mail What does AI literacy actually look like for pathologists, researchers, and future clinicians? And how do you teach it in a way that is practical, not abstract? In this episode, I talk with Candice Chu, DVM, PhD about something I think a lot of people in digital pathology and computational pathology are feeling right now: AI is moving fast, but education is still catching up.… [Listen](https://www.buzzsprout.com/410071/episodes/19435440-243-how-to-teach-ai-to-healthcare-professionals-podcast-with-candice-chu.mp3) ## [Hacking the Medical System: How Necessity Drove Change But Not Adoption](https://beyondtheslide.substack.com/p/hacking-the-medical-system-how-necessity) _2026-06-26 · Dr. Luis Cano · Beyond the Slide_ How the industry built smarter algorithms when hospitals needed simpler systems and what happened when clinicians started fixing it themselves ## 242: Foundation Models in Pathology: Strong on Paper, Ready for Labs? _2026-06-24 · Digital Pathology Podcast_ Send us Fan Mail Are pathology foundation models actually ready for labs, or are they still stronger on paper than in practice? In this episode of DigiPath Digest #49 , I unpack a timely review on pathology foundation models and ask the question that matters most to me: not just what these models can do , but what has to be true before they are genuinely useful in real pathology workflows . I walk… [Listen](https://www.buzzsprout.com/410071/episodes/19394771-242-foundation-models-in-pathology-strong-on-paper-ready-for-labs.mp3) ## [The Proximity Paradox of Digital Pathology](https://beyondtheslide.substack.com/p/the-proximity-paradox-of-digital) _2026-06-19 · Dr. Luis Cano · Beyond the Slide_ How a technology designed to connect experts may be quietly weakening the invisible networks that make diagnosis possible. ## 241: AI-Powered Companion Diagnostics: The Future of Precision Medicine | Podcast with Doug Bowman, VP Precision Medicine at Indica Labs, Inc. _2026-06-17 · Digital Pathology Podcast_ Send us Fan Mail How far can pathologists take visual biomarker scoring before human vision becomes the bottleneck? In this episode, I talk with Doug Bowman. PhD, VP Precision Medicine at Indica Labs , about what happens when companion diagnostics move from traditional visual scoring into the era of AI-powered image analysis . Doug comes from a biomedical and electrical engineering background,… [Listen](https://www.buzzsprout.com/410071/episodes/19359324-241-ai-powered-companion-diagnostics-the-future-of-precision-medicine-podcast-with-doug-bowman-vp-precision-medicine-at-indica-labs-inc.mp3) ## [The Most Expensive Experiment in Modern Biology](https://beyondtheslide.substack.com/p/the-most-expensive-experiment-in) _2026-06-12 · Dr. Luis Cano · Beyond the Slide_ How technology-first thinking destroys R&D programs before they begin ## [Is Pharma Ready for AI?, Or Has It Confused Investment with Capability?](https://beyondtheslide.substack.com/p/is-pharma-ready-for-ai-or-has-it) _2026-06-05 · Dr. Luis Cano · Beyond the Slide_ THE PROMISE : The biggest technology boom in the history of the pharmaceutical industry ## 240: Can AI Copilots Keep Up with Pathologists? _2026-06-03 · Digital Pathology Podcast_ Send us Fan Mail Can AI copilots really keep up with pathologists when the cases are new, the workflow is messy, and the benchmark is actually protected from leakage? In this episode of DigiPath Digest #48 , I focus on one paper: DALPHIN: Benchmarking Digital Pathology AI Copilots Against Pathologists on an Open Multicentric Dataset . I chose this paper because I think the field needs more of this… [Listen](https://www.buzzsprout.com/410071/episodes/19288089-240-can-ai-copilots-keep-up-with-pathologists.mp3) ## [Privacy-first AI-native browser (Sponsored)](https://crawlproof.com/a/8f5B6Gg4rFn9) _2026-06-03 · **Sponsored**_ No telemetry or ads — built on Ungoogled Chromium with a built-in AI sidebar and CLI. ## [The Problem Is Not the Model. It’s the Meeting After the Model.](https://beyondtheslide.substack.com/p/the-problem-is-not-the-model-its) _2026-05-29 · Dr. Luis Cano · Beyond the Slide_ AI is already producing useful predictions, what organizations still don’t know how to produce are decisions ## 239: The Four Steps Pathology AI Demos Quietly Skip and Why They Matter _2026-05-28 · Digital Pathology Podcast_ Send us Fan Mail What happens when a pathology AI model misses the tissue before it even begins—and can better segmentation, education, and virtual staining close the gaps? In DigiPath Digest #47, I review four recent studies that expose both the promise and the weak points of AI-assisted digital pathology. We start with a step that sounds simple: detecting tissue on a whole slide image. Yet when… [Listen](https://www.buzzsprout.com/410071/episodes/19617420-239-the-four-steps-pathology-ai-demos-quietly-skip-and-why-they-matter.mp3) ## [The Translation Gap](https://beyondtheslide.substack.com/p/the-translation-gap) _2026-05-22 · Dr. Luis Cano · Beyond the Slide_ Why modern biomedical organizations generate biological intelligence faster than they can operationalize it ## 238: How Do We Know AI Is Ready for Pathology _2026-05-19 · Digital Pathology Podcast_ Send us Fan Mail Do you really need a scanner, whole slide images, and AI infrastructure before you can start in digital pathology? In this episode, I argue that you do not. I’m Dr. Aleksandra Zuraw, veterinary pathologist and digital pathology educator, and this talk is about a belief I hear all the time: I don’t have the tools yet, so there is no point learning digital pathology. I used to think… [Listen](https://www.buzzsprout.com/410071/episodes/19202570-238-how-do-we-know-ai-is-ready-for-pathology.mp3) ## [The Domestication of Medical AI: How Europe selects which forms of clinical intelligence get to survive](https://beyondtheslide.substack.com/p/the-domestication-of-medical-ai-how) _2026-05-15 · Dr. Luis Cano · Beyond the Slide_ Earlier this year, physicians across the UK and EU opened their laptops to find that OpenEvidence, a clinical AI platform used by more than 40% of doctors across 10,000 US hospitals, had gone dark overnight. ## [From Photograph to Video, The New Science of Measuring Disease: Rethinking Endpoints in the Age of AI (Part 4)](https://beyondtheslide.substack.com/p/from-photograph-to-video-the-new) _2026-05-08 · Dr. Luis Cano · Beyond the Slide_ In the first article of this series, we corrected a misunderstanding: the FDA did not approve an AI-based endpoint. ## [The Gold Standard Was Made of Clay. Why Histology Was Never Enough. Rethinking Endpoints in the Age of AI (Part 3b)](https://beyondtheslide.substack.com/p/the-gold-standard-was-made-of-clay) _2026-05-01 · Dr. Luis Cano · Beyond the Slide_ In the previous chapter of this series, we explored the gap between what evidence promises and what patients experience. ## [The Trial Says It Works. Your Patient Disagrees: Rethinking Endpoints in the Age of AI (Part 3)](https://beyondtheslide.substack.com/p/the-trial-says-it-works-your-patient) _2026-04-24 · Dr. Luis Cano · Beyond the Slide_ In the previous chapter, we left a question unanswered. ## [Beyond the Loop: AI as an Extension of Clinical Reasoning](https://beyondtheslide.substack.com/p/beyond-the-loop-ai-as-an-extension) _2026-04-10 · Dr. Luis Cano · Beyond the Slide_ If the problem wasn’t a lack of supervision, the solution can’t be more supervision either. ## [The Illusion of Control: Why "Human in the Loop" Is Clinical AI's Biggest Regulatory Fiction](https://beyondtheslide.substack.com/p/the-illusion-of-control-why-human) _2026-04-03 · Dr. Luis Cano · Beyond the Slide_ This is a detour from my series on endpoints and digital pathology but this topic keeps generating questions I can't ignore: where are we actually going, and how? ## [Reach prospects with real signals (Sponsored)](https://crawlproof.com/a/ctAY2wArsnrq) _2026-04-03 · **Sponsored**_ Find prospects talking about your problem and get context-backed moments to engage ## [An Endpoint Is Not a Biomarker, and That Difference Can Kill a Drug : Rethinking Endpoints in the Age of AI (Part 2)](https://beyondtheslide.substack.com/p/an-endpoint-is-not-a-biomarker-and) _2026-03-27 · Dr. Luis Cano · Beyond the Slide_ In the previous chapter, we looked at a case that generated considerable noise in the community: the supposed “approval of an AI-based endpoint.”